Risk Factors for Major Adverse Cardiovascular Events in Rheumatoid Arthritis Patients Treated with Tocilizumab

被引：0
|
作者：
Rao, Vijay [1 ]
Pavlov, Andrey [2 ]
Klearman, Micki [1 ]
Musselman, David [3 ]
Giles, Jon T. [4 ]
Bathon, Joan M. [4 ]
Sattar, Naveed [5 ]
Lee, Janet S. [3 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Everest, Toronto, ON, Canada
[3] Roche, Nutley, NJ USA
[4] Columbia Univ, Med Ctr, New York, NY USA
[5] Univ Glasgow, Glasgow, Lanark, Scotland
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1642
引用
收藏
页码：S642 / S642
页数：1
相关论文
共 50 条
  • [31] Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE
    Morel, Jacques
    Constantin, Arnaud
    Baron, Gabriel
    Dernis, Emmanuelle
    Flipo, Rene Marc
    Rist, Stephanie
    Combe, Bernard
    Gottenberg, Jacques Eric
    Schaeverbeke, Thierry
    Soubrier, Martin
    Vittecoq, Olivier
    Dougados, Maxime
    Saraux, Alain
    Mariette, Xavier
    Ravaud, Philippe
    Sibilia, Jean
    RHEUMATOLOGY, 2017, 56 (10) : 1746 - 1754
  • [32] Hydroxychloroquine Use Is Associated with a Lower Risk of Major Adverse Cardiovascular Events in Medicare Recipients with Rheumatoid Arthritis
    Iyer, Priyanka
    Gao, Yubo
    Girotra, Saket
    Curtis, Jeffrey
    Vaughan-Sarrazin, Mary
    Singh, Namrata
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [33] Cardiovascular events and change in cholesterol levels in patients with rheumatoid arthritis treated with tocilizumab: data from the REGATE Registry
    Lukas, C.
    Redondin, M.
    Pane, I
    Soubrier, M.
    Houvenagel, E.
    Sibilia, J.
    Combe, B.
    Morel, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 39 (03) : 501 - 507
  • [34] CARDIOVASCULAR AND ADVERSE EVENTS RISK WITH TOFACITINIB IN RHEUMATOID ARTHRITIS IN THE DOMINICAN REPUBLIC
    Alvarez Santana, R. A.
    Garcia, D.
    Perez, L.
    Polanco Mora, T.
    Concepcion Sanchez, L.
    Paulino, I.
    Mercedes, I.
    Rodriguez Bautista, E.
    Valdez, T.
    Feriz, A.
    Munoz Louis, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1446 - 1447
  • [35] Cardiovascular risk factors in patients with rheumatoid arthritis
    Ng, W
    Hall, A
    Steuer, A
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 146 - 146
  • [36] Relative risk of cardiovascular events in patients with rheumatoid arthritis
    DeMaria, AN
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (6A): : 33D - 38D
  • [37] TOCILIZUMAB IS WELL TOLERATED IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH A LOW RATE OF SERIOUS ADVERSE EVENTS
    Smolen, J. S.
    Beaulieu, A. D.
    Dikranian, A.
    Fenton, I.
    Fisheleva, E.
    Alecock, E.
    Emery, P.
    RHEUMATOLOGY, 2009, 48 : I87 - I87
  • [38] Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatment
    de Thurah, Annette
    Andersen, Ina Trolle
    Tinggaard, Andreas Bugge
    Riis, Anders Hammerich
    Therkildsen, Josephine
    Botker, Hans Erik
    Bottcher, Morthen
    Hauge, Ellen-Margrethe
    RMD OPEN, 2020, 6 (01):
  • [39] Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis
    Lauper, Kim
    Courvoisier, Delphine S.
    Chevallier, Paola
    Finckh, Axel
    Gabay, Cem
    ARTHRITIS CARE & RESEARCH, 2018, 70 (12) : 1756 - 1763
  • [40] Prediction of Major Adverse Cardiovascular Events by Triglyceride Glucose Index in Predominantly Male Patients with Rheumatoid Arthritis
    Zhang, Jiawei
    Hou, Qiqi
    Han, Quanle
    Peng, Xu
    Cao, Hongxia
    Wu, Shouling
    Li, Kangbo
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (01)
12345